Low-level postoperative carcinoembryonic antigen improves survival outcomes stratification in patients with stage II colon cancer treated with standard adjuvant treatments.

Posté par : Pr. Franck BONNETAIN, Dr. Dewi VERNEREY

Nom de la revue : European Journal of Cancer